Dr James Garner - Kazia Therapeutics - A novel approach to novel drug development

Dr James Garner is the CEO of Kazia Therapeutics, an oncology-focused biotechnology company developing innovative anti-cancer drugs. It was great to chat with James about the development of Paxalisib a drug that is being tested for use in the treatment of brain tumours. He also shared some interesting insights into how drugs are developed and tested now. It's a sector that is benefiting from the streamlining of drug testing and novel paths to innovation.